PPA
CODX

Parametric Portfolio Associates’s Co-Diagnostics CODX Stock Holding History

Parametric Portfolio Associates’s Portfolio CODX Stock Details CODX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.05M Sell
11,047
-7,248
-40% -$1.5M ﹤0.01% 2413
2021
Q4 		$4.9M Buy
18,295
+748
+4% +$196K ﹤0.01% 1871
2021
Q3 		$5.12M Buy
17,547
+1,220
+7% +$356K ﹤0.01% 1812
2021
Q2 		$4.04M Buy
16,327
+12,128
+289% +$3.12M ﹤0.01% 1989
2021
Q1 		$1.2M Buy
+4,199
New +$1.68M ﹤0.01% 3079

Other funds holding CODX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ARC
Advisor Resource Council Dallas, Texas $355M AUM 30.05% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return
EGM
Engineers Gate Manager New York $8B AUM 17.32% 1-Year Est. Return

Parametric Portfolio Associates's CODX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Co-Diagnostics (CODX) stake by 40% in Q1 2022, selling an estimated $1.5M and leaving 11,047 shares worth $2.05M. The position accounts for ﹤0.01% of the portfolio, ranked #2413.

Parametric Portfolio Associates first reported a position in CODX in Q1 2021 and has held it in 5 quarters since. The position peaked at $5.12M in Q3 2021. 82 funds tracked by Wall St. Rank hold CODX as of Q1 2022.

  • Parametric Portfolio Associates held 11,047 shares of Co-Diagnostics worth $2.05M as of Q1 2022.
  • Parametric Portfolio Associates sold 7,248 Co-Diagnostics shares in Q1 2022, an estimated $1.5M.
  • Co-Diagnostics made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2413 holding.
  • Parametric Portfolio Associates first reported a position in Co-Diagnostics in Q1 2021 and has held it in 5 quarters since.
  • Parametric Portfolio Associates's Co-Diagnostics position peaked at $5.12M in Q3 2021.
  • 82 funds tracked by Wall St. Rank held Co-Diagnostics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.